Prime Medicine, Inc. (PRME)
NASDAQ: PRME · IEX Real-Time Price · USD
4.425
+0.125 (2.91%)
At close: Apr 26, 2024, 4:00 PM
4.500
+0.075 (1.69%)
After-hours: Apr 26, 2024, 6:32 PM EDT
Prime Medicine Market Cap
Prime Medicine has a market cap or net worth of $530.73 million as of April 26, 2024. Its market cap has decreased by -60.45% in one year.
Market Cap
530.73M
Enterprise Value
418.20M
1-Year Change
-60.45%
Ranking
Category
Stock Price
$4.43
Market Cap Chart
Since the IPO on October 20, 2022, Prime Medicine's market cap has decreased from $1.63B to $530.73M, a decrease of -67.39%. That is a compound annual growth rate of -52.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 25, 2024 | 515.70M | -8.52% |
| Apr 24, 2024 | 563.70M | -2.08% |
| Apr 23, 2024 | 575.70M | 0.42% |
| Apr 22, 2024 | 573.30M | 5.99% |
| Apr 19, 2024 | 540.90M | -1.74% |
| Apr 18, 2024 | 550.50M | -6.90% |
| Apr 17, 2024 | 591.30M | -6.45% |
| Apr 16, 2024 | 632.10M | -3.13% |
| Apr 15, 2024 | 652.50M | -5.06% |
| Apr 12, 2024 | 687.30M | -1.36% |
| Apr 11, 2024 | 696.80M | -1.36% |
| Apr 10, 2024 | 706.40M | -4.70% |
| Apr 9, 2024 | 741.20M | 1.31% |
| Apr 8, 2024 | 731.60M | 6.08% |
| Apr 5, 2024 | 689.70M | -0.68% |
| Apr 4, 2024 | 694.40M | -0.17% |
| Apr 3, 2024 | 695.60M | -8.23% |
| Apr 2, 2024 | 758.00M | -6.51% |
| Apr 1, 2024 | 810.80M | -3.43% |
| Mar 28, 2024 | 839.60M | 3.55% |
| Mar 27, 2024 | 810.80M | 1.50% |
| Mar 26, 2024 | 798.80M | -3.06% |
| Mar 25, 2024 | 824.00M | -0.87% |
| Mar 22, 2024 | 831.20M | -5.59% |
| Mar 21, 2024 | 880.40M | -0.41% |
View and export this data all the way back to 2022.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Talkspace | 520.22M |
| OmniAb | 518.87M |
| CureVac | 517.17M |
| ORIC Pharmaceuticals | 516.77M |
| InnovAge Holding | 516.42M |
| Nano-X Imaging | 511.06M |
| Altimmune | 510.45M |
| AnaptysBio | 505.02M |